(Q36843661)

16 August 2017

A detailed safety assessment of a saw palmetto extract (English)

1 reference

16 August 2017

Andrew L Avins

1

1 reference

16 August 2017

Stephen Bent

2

1 reference

16 August 2017

Suzanne Staccone

3

1 reference

16 August 2017

Evelyn Badua

4

1 reference

16 August 2017

Amy Padula

5

1 reference

16 August 2017

Harley Goldberg

6

1 reference

16 August 2017

John Neuhaus

7

1 reference

16 August 2017

Esther Hudes

8

1 reference

16 August 2017

Katusto Shinohara

9

1 reference

16 August 2017

Christopher Kane

10

1 reference

16 August 2017

20 February 2008

1 reference

Complementary Therapies in Medicine

16 August 2017

1 reference

16 August 2017

16

1 reference

16 August 2017

3

1 reference

16 August 2017

147-154

1 reference

Saw palmetto and lower urinary tract symptoms: what is the latest evidence?

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Saw palmetto for benign prostatic hyperplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Complementary and alternative medicine use among adults: United States, 2002

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Phytotherapeutic agents in the treatment of benign prostatic hyperplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Phytotherapy in the treatment of benign prostatic hyperplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Phytotherapy for benign prostatic hyperplasia

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

29 September 2017

12 December 2020

Americans' views on the use and regulation of dietary supplements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Epidemiology and natural history of benign prostatic hyperplasia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Use of alternative health care by family practice patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Disclosure of Natural Product Use to Primary Care Physicians: A Cross-sectional Survey of Naturopathic Clinic Attendees

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518869

Serenoa repens for benign prostatic hyperplasia

20 October 2018

1 reference

12 December 2020

Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey

1 reference

12 December 2020

Variations in Product Choices of Frequently Purchased Herbs

1 reference

12 December 2020

Saw palmetto-induced pancreatitis

1 reference

12 December 2020

Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats

1 reference

12 December 2020

A brief male sexual function inventory for urology

1 reference

12 December 2020

Protracted cholestatic hepatitis after the use of prostata

1 reference

12 December 2020

10.1016/J.CTIM.2007.10.005

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18534327

1 reference